Overview of Dr. Barbieri
Dr. Christopher Barbieri is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He is one of 184 doctors at New York-Presbyterian Hospital and one of 59 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 100 publications and over 500 citings.
Office
525 East 68th Street
Starr 900
New York, NY 10065- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2009 - 2024- American Board of Urology Urology
Awards, Honors, & Recognition
- MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016
- Rising Star in Urology Research Urology Care Foundation / AUA, 2015
- Challenge Award Prostate Cancer Foundation, 2014
- Join now to see all
Publications & Presentations
PubMed
- Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort.Elisa Benedetti, Kelsey Chetnik, Thomas Flynn, Christopher E Barbieri, Douglas S Scherr, Massimo Loda, Jan Krumsiek> ;Scientific Data. 2023 Nov 25
- 2 citationsDifferential Use of Radiotherapy Fractionation Regimens in Prostate Cancer.Sarah A Qureshy, Marshall A Diven, Xiaoyue Ma, Ariel E Marciscano, Jim C Hu, Tim D McClure, Christopher Barbieri, Himanshu Nagar> ;JAMA Network Open. 2023 Oct 2
- 2 citationsRandomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E Barbieri, Silvia C Formenti, Jim C Hu, Ana M Molina, David M Nanus, Jones T Nauseef, Douglas S Scherr, C...> ;BMC Cancer. 2023 Aug 22
- Join now to see all
Journal Articles
- Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation RatesChristopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
- Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”Christopher Barbieri, MD, Urologic Oncology
- Molecular Subtypes of Prostate CancerChristopher Barbieri, MD, Current Oncology Reports
Authored Content
- SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018
Press Mentions
Study Zeros in on Why Men Abandon Prostate Cancer Active SurveillanceOctober 25th, 2021
Damon Runyon Cancer Research Foundation Announces New Physician-Scientist Training AwardsMay 13th, 2019
Rising Star Lecturer: Molecular Criteria Can Help Urologists More Accurately Assess Prostate CancerMay 5th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York- New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
